[{"NetIncomeLoss_1_Q2_USD":-18839000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":30551736.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":4333000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":296000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":25576000.0,"Depreciation_1_Q2_USD":200000.0,"Depreciation_2_Q2_USD":465000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":804975.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3261000.0,"AssetsCurrent_0_Q2_USD":201165000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":127302000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3035504.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3172000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":157107000.0,"CommonStockSharesIssued_0_Q2_shares":24162876.0,"Assets_0_Q2_USD":229057000.0,"ShareBasedCompensation_2_Q2_USD":3278000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":12872000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":6385684.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":15.96,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":1265000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":30521600.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":3008000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":4388000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":2.9,"ResearchAndDevelopmentExpense_2_Q2_USD":29602000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":15019000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":13.95,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":14772000.0,"InvestmentsAndCash_0_Q2_USD":203100000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":894000.0,"ProceedsFromStockPlans_2_Q2_USD":317000.0,"CommonStockValue_0_Q2_USD":242000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":5034000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-212000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-36210000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-18748000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":2227000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-905000.0,"OtherAssetsNoncurrent_0_Q2_USD":258000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":31791000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":10932000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":350019000.0,"Liabilities_0_Q2_USD":22104000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":253000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":91000.0,"OperatingLeaseLiability_0_Q2_USD":13507000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"GeneralAndAdministrativeExpense_2_Q2_USD":8378000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-3545000.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"OperatingIncomeLoss_2_Q2_USD":-37980000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":1729000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":568000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1924000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-29464000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3086000.0,"LiabilitiesCurrent_0_Q2_USD":11172000.0,"AccountsPayableCurrent_0_Q2_USD":4264000.0,"NonoperatingIncomeExpense_2_Q2_USD":1517000.0,"NonoperatingIncomeExpense_1_Q2_USD":568000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3075000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":39000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":9000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.038,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":31791000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":94303.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":317000.0,"OperatingLeasePayments_2_Q2_USD":1490000.0,"OperatingLeasePayments_1_Q2_USD":750000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":3044000.0,"DividendsCommonStock_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":9728000.0,"NetIncomeLoss_2_Q2_USD":-36463000.0,"CommonStockSharesOutstanding_0_Q2_shares":24162876.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-4100000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-143668000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1180003.0,"OperatingIncomeLoss_1_Q2_USD":-19407000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":166299000.0,"IncreaseDecreaseInIncomeTaxesReceivable_2_Q2_USD":-35000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":42.64,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":1.31,"OperatingLeaseCost_2_Q2_USD":1534000.0,"OperatingLeaseCost_1_Q2_USD":767000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":229057000.0,"PreferredStockSharesAuthorized_0_Q2_shares":200000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":25334.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1512000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":11457000.0,"OperatingExpenses_2_Q2_USD":37980000.0,"OperatingExpenses_1_Q2_USD":19407000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.19,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.62,"ProfitLoss_2_Q2_USD":-36463000.0,"StockholdersEquity_0_Q2_USD":206953000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":4229000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":358000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":2974547.0,"VariableLeaseCost_2_Q2_USD":114000.0,"VariableLeaseCost_1_Q2_USD":68000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2575000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":445000.0,"Ticker":"IGMS","CIK":"1496323","name":"IGM BIOSCIENCES, INC.","OfficialName":"IGM Biosciences Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"806397058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]